ALVOW
Alvotech
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IS
$0.30
−6.25%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 1Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| OAKTREE CAPITAL MANAGEMENT LP | Unchanged | 4,666,667 | May 20, 2026 |
| LINDEN ADVISORS LP | Unchanged | 252,884 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Unchanged | 69,711 | May 15, 2026 |
| JANE STREET GROUP, LLC | Unchanged | 56,252 | May 12, 2026 |
| MOORE CAPITAL MANAGEMENT, LP | Unchanged | 50,000 | May 15, 2026 |
| DEUTSCHE BANK AG\ | Unchanged | 46,769 | May 6, 2026 |
| SCULPTOR CAPITAL LP | Unchanged | 3,702 | May 15, 2026 |
| UBS GROUP AG | Reduced | 373 | May 5, 2026 |
| Sculptor Capital LP | Sold Out | 0 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | 0 | May 15, 2026 |
| DEUTSCHE BANK AG\ | Sold Out | 0 | May 6, 2026 |
| LINDEN ADVISORS LP | Sold Out | 0 | May 15, 2026 |
| JANE STREET GROUP, LLC | Sold Out | 0 | May 12, 2026 |
| OAKTREE CAPITAL MANAGEMENT LP | Sold Out | 0 | May 20, 2026 |
| MOORE CAPITAL MANAGEMENT, LP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings